Skip to main content
. 2025 Feb 21;15(3):144. doi: 10.3390/metabo15030144
ICIs Immune checkpoint inhibitors
PD-1 Programmed cell death 1
CTLA-4 Cytotoxic T lymphocyte-associated antigen-4
Trp Tryptophan
NAD+ Nicotinamide adenine dinucleotide
IDO Indoleamine 2,3-dioxygenase
13AA Indole-3-acetaldehyde
HCC Hepatocellular carcinoma
ROS Reactive oxygen species
BH4 Tetrahydrobiopterin
IFNγ Interferon γ
USP14 Ubiquitin-specific protease-14
Treg Regulatory T cells
ORR Overall response rate
MAPK Mitogen activated protein kinases
NSCLC Non-small cell lung cancer
TNBC Triple negative breast cancer
VEGFR2 Vascular endothelial growth factor receptor 2
GLS Glutaminase
TME Tumor microenvironment
αKG α-ketoglutarate